CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
The approval of Veklury was supported by the agency’s analysis of data from three randomized, controlled clinical trials that included patients hospitalized with mild to severe COVID-19.
Gilead Sciences, 650-574-3000
Pages: 1 2
The approval of Veklury was supported by the agency’s analysis of data from three randomized, controlled clinical trials that included patients hospitalized with mild to severe COVID-19.
Gilead Sciences, 650-574-3000
Tagged with: Gilead Sciences